IRIS
ANGARANO, Gioacchino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.807
EU - Europa 4.737
AS - Asia 2.349
SA - Sud America 18
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 26.939
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.784
CN - Cina 1.528
DE - Germania 1.317
SE - Svezia 850
UA - Ucraina 804
SG - Singapore 621
IT - Italia 575
FI - Finlandia 488
GB - Regno Unito 333
FR - Francia 80
RU - Federazione Russa 68
IN - India 64
BE - Belgio 63
IE - Irlanda 49
VN - Vietnam 48
MK - Macedonia 25
IR - Iran 22
CA - Canada 18
HK - Hong Kong 18
BR - Brasile 13
TR - Turchia 11
EU - Europa 10
RO - Romania 10
GE - Georgia 9
HR - Croazia 9
NL - Olanda 9
PL - Polonia 9
CZ - Repubblica Ceca 8
GR - Grecia 8
AT - Austria 5
CH - Svizzera 5
ID - Indonesia 5
ZA - Sudafrica 5
ES - Italia 4
HU - Ungheria 4
RS - Serbia 4
AU - Australia 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MX - Messico 3
AR - Argentina 2
AZ - Azerbaigian 2
BH - Bahrain 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MY - Malesia 2
NG - Nigeria 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KR - Corea 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 26.939
Salva come PNG Salva come JPEG
Città #
Fairfield 2.754
Woodbridge 2.030
Jacksonville 1.876
Chandler 1.702
Houston 1.486
Ashburn 1.254
Seattle 1.123
Wilmington 1.010
Cambridge 913
Ann Arbor 853
Nyköping 579
Lawrence 465
Roxbury 463
Singapore 458
Nanjing 450
Des Moines 287
Boardman 274
New York 253
Beijing 246
Princeton 231
Shenyang 127
Hebei 122
Inglewood 119
Bari 111
Dearborn 111
Nanchang 111
San Diego 111
Santa Clara 85
Jiaxing 71
Tianjin 69
Los Angeles 66
Brooklyn 63
Helsinki 55
Brussels 48
Dublin 48
Dong Ket 46
London 41
Munich 41
Pune 40
Guangzhou 37
Changsha 36
Milan 36
Rome 30
Paris 29
Hefei 28
Taranto 27
Washington 22
Auburn Hills 21
Falls Church 21
Norwalk 21
Jinan 20
Zhengzhou 20
Redwood City 19
Kunming 17
San Mateo 15
Ardabil 14
Ningbo 14
Prilep 14
Kilburn 13
Espoo 12
Leawood 12
Shanghai 11
Hangzhou 8
Mong Kok 8
Romola 8
Taizhou 8
Zagreb 8
Indiana 7
Monmouth Junction 7
Wuhan 7
Amsterdam 6
Bergamo 6
Hong Kong 6
Naples 6
Toronto 6
Augusta 5
Chiswick 5
Redmond 5
San Francisco 5
Shenzhen 5
Skopje 5
Tappahannock 5
Vignola 5
Warsaw 5
Bologna 4
Brescia 4
Budapest 4
Florence 4
Grafing 4
Hounslow 4
Islington 4
Montreal 4
Palermo 4
Triggiano 4
Uster 4
Weimar 4
Alcamo 3
Athens 3
Brno 3
Catania 3
Totale 20.877
Salva come PNG Salva come JPEG
Nome #
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 272
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 149
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 143
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 138
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 133
Access to health services for undocumented immigrants in Apulia. 128
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 127
Access to HAART in HIV-Infected Immigrants: A Retrospective Multicenter Italian Study 125
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 118
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 117
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 116
Co-receptor switch during HAART is independent of virological success 116
Cryptosporidiosis in the acquired immunodeficiency syndrome: a case report 115
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 115
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 115
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 113
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 112
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 110
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 108
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 107
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 107
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. 106
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 105
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 105
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 104
The elderly and direct antiviral agents: Constraint or challenge? 102
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 101
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 100
An outbreak of HIV-1 BC recombinants in Southern Italy 99
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 98
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 98
Intrathecal immune response in human immunodeficiency virus infection 97
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin. 97
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis 96
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 96
Sphingomonas paucimobilis outbreak in a dialysis room: Case report and literature review of an emerging healthcare associated infection 96
Persistence of e antigen as prognostic marker in acute hepatitis B 95
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 95
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study 94
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy 94
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 94
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 94
Access to Health Services for Undocumented Immigrants in Apulia 93
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 93
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 93
Radioimmunoassay diagnosis of hepatitis type A 92
A cyanobacterium-like body found in the stools of an HIV+ patient with diarrhoea 92
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years 92
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. 92
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 92
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients 92
Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors 90
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients 90
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection 89
Cryptococcal Meningitis 89
Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males 89
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 89
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 89
Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens 89
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents 89
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 89
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 89
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 88
Splenic abscesses as a first manifestation of Crohn's disease: A case report 88
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 87
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 87
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 87
Cell cultures from small amounts of heparinized whole blood enhance HIV-1 isolation rate 86
Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases 86
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin 86
Effects of HIV superinfection on HBV replication in a chronic HbsAg carrier with liver disease 85
Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study 85
Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 85
Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy 84
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 84
Ciprofloxacin for treating cholera 83
HIV-1 variability and progression to AIDS: a longitudinal study 83
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 83
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users 82
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to female heterosexual transmission 82
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 82
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs? 82
Reproductive choice in individuals HIV-1 infected in South Eastern Italy 82
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 82
null 81
Immunological markers in HIV-infected pregnant and non-pregnant women 81
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 81
Are the proposed env mutations actually associated with resistance to maraviroc? 81
Survival of Zidovudine-treated patients with AIDS compared with that of contemporary untreated patients 80
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors 80
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-a 80
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 80
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 80
Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America 80
Alterazioni oftalmoscopiche e fluorangiografiche in pazienti affetti da AIDS 79
Familial clustering of HBV pre-C and pre-S mutants 79
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women 79
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 79
Biological correlates of HIV-1 heterosexual transmission 79
Opportunistic parasitic infections of the intestinal tract in the era of highly active antiretroviral therapy: is the cd4+ count so important? 79
Totale 9.699
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.803 0 0 0 0 816 464 814 616 886 406 635 166
2020/20214.257 442 306 394 256 538 214 473 207 450 541 252 184
2021/20222.804 111 371 36 233 138 186 103 197 186 173 451 619
2022/20234.434 798 318 186 448 628 517 40 502 772 34 102 89
2023/20241.506 144 345 83 75 96 394 39 39 28 41 30 192
2024/20251.218 90 118 690 214 106 0 0 0 0 0 0 0
Totale 27.570